By CreakyStaff
Here’s what our patient community shared about how insurance-related challenges affect well-being, how to navigate hurdles like prior authorization, and ways to discuss insurance with your health care providers.
By Shani Erdman
Rheumatology leaders and patient advocates convene on Capitol Hill to advocate for legislation to improve patient access to care.
By Kerry Weiss
This go-to medication has become harder to access for some, making it a good time to re-evaluate your treatment plan.
By Susan Jara
The chronic illness community may be experiencing an unexpected side effect of abortion restrictions — issues accessing methotrexate.
By CreakyStaff
ACR researchers shed light on some of the many health disparities interfering with diagnosis, quality of treatment, and other aspects of care for patients with rheumatic disease. Fixing these widespread disparities will not be easy, but it starts with identifying and understanding what may be causing them.
The $1.9 trillion virus relief bill is more than just stimulus checks or extended unemployment benefits. Here’s a look at how it impacts health insurance costs, which is particularly important for people living with chronic illness.
From copays and insurance premiums to indirect costs like assistive devices and loss of income from chronic pain, arthritis is expensive. Here, people living with arthritis get real about how their conditions affect their finances — and how their finances affect their conditions.
By Joseph Coe
When arthritis and disability patient advocates Laurie Proulx of the Canadian Arthritis Patient Alliance, Simon Stone, and CreakyJoints teamed up for a Twitter chat about managing arthritis in the workplace, the entire arthritis community benefits from sharing experiences and knowledge.
By CreakyStaff
Reopening states too quickly is not safe for anyone, but it is especially risky for people who are immunocompromised or at a higher risk for COVID-19 complications. Patients are speaking out to save lives.
We need to ensure that patients who depend on these medications on a daily basis to manage their rheumatologic diseases have access to them during the coronavirus pandemic.
By CreakyStaff
‘Restricting lupus, rheumatoid arthritis, and other rheumatology patients from accessing hydroxychloroquine is wrong.’
By CreakyStaff
If you are a patient living with a chronic illness and are having trouble getting access to hydroxychloroquine (Plaquenil), we want to hear from you.
By Joseph Coe
Proceed with caution, and follow these tips, before you donate money or time to a charity.
We have to talk more about how these straw bans are negatively impacting those of us with disabilities — and what we can do to reverse the trend.
A new study demonstrated just how these insurance requirements have a negative impact on patient care.
By CreakyStaff
We applaud legislators in Albany for passing non-medical switching.
By CreakyStaff
“You have to be passionate about helping people with chronic illness, and be willing to reach out to the community to make sure that we all have a better life.”
These programs offer substantial out-of-pocket savings on expensive drugs, but they’re becoming controversial in certain states. Learn the facts here.
By CreakyStaff
Brenda Kleinsasser was diagnosed with rheumatoid arthritis before the advent of biologics. Good thing she kept fighting.
By CreakyStaff
Diagnosed with rheumatoid arthritis, Jennifer Walker shares what compelled her to be a patient advocate and a Patient Governor for ArthritisPower.
By CreakyStaff
The recent headlines abound. “Why McConnell’s New Health Care Rule Could Be a Death Sentence,” says Vanity Fair. Vox offered a concrete number. “208,500 additional deaths could occur by 2026 under the Senate health plan,” it states. A Washington Post...
By CreakyStaff
Socialized medicine, a term which appears to be on the rise of late in Google searches, has been garnering headlines. “Whether you blame socialized medicine or soaring secularization, it’s no secret that European medicine and law hold ever-less respect for...
By CreakyStaff
While Michael Morrissey, Ph.D., a health policy expert from Texas A&M University, calls the Senate health bill a “mixed bag,” Dr. Daniel Derksen of the University of Arizona School of Public Health takes a far more negative view. On the...
By Joseph Coe
Advocacy Joe wonders: Is the struggle for equality and justice over?
By 
By 
By 
By 
